# Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy

> **NCT07036796** · PHASE2 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy
- Diabetic Neuropathy
- Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT07036796
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-04
- **Primary completion:** 2026-07-04
- **Final completion:** 2026-07-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036796, "Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07036796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
